Press Releases HBM Healthcare Investments AG

Equities

Market Closed - Swiss Exchange Other stock markets 11:30:41 2023-12-08 am EST			5-day change	1st Jan Change
170 ^CHF	-2.30%		-2.86%	-15.42%

Dec. 01	AbbVie to Buy Cancer-focused ImmunoGen for $10.1 Billion	MT
Nov. 21	Kepler Cheuvreux Lowers Price Target on HBM Healthcare Investments, Maintains Buy Recommendation	MT

Key Figures 30.11.2023	Dec. 01	EQ
AbbVie to acquire HBM portfolio company ImmunoGen for USD 10.1 billion in cash	Nov. 30	EQ
Key Figures 15.11.2023	Nov. 16	EQ
Key Figures 31.10.2023	Nov. 02	EQ
Key Figures 15.10.2023	Oct. 16	EQ
HBM Healthcare Investments activates share buyback programme	Oct. 16	EQ
HBM Healthcare Investments publishes Half-Year Report as at 30 September 2023 with key figures for the second quarter of the 2023/2024 financial year	Oct. 16	EQ
HBM Healthcare Investments : Half-Year Report September 2023	Oct. 11	PU
Key Figures 30.09.2023	Oct. 02	EQ
HBM Healthcare Investments publishes Net Asset Value per Share (NAV) of CHF 237.22 as at 30 September 2023	Oct. 02	EQ
Key Figures 15.09.2023	Sep. 18	EQ
Key Figures 31.08.2023	Sep. 01	EQ
Key Figures 15.08.2023	Aug. 16	EQ
Key Figures 31.07.2023	Aug. 02	EQ
HBM Healthcare Investments publishes interim report for the quarter ended 30 June 2023 with key figures for the first three months of the 2023/2024 financial year	Jul. 21	EQ
Key Figures 15.07.2023	Jul. 17	EQ
Key Figures 30.06.2023	Jul. 03	EQ
Cathay Biotech raises capital and enters into major strategic collaboration with China Merchants Group	Jun. 26	EQ
Shareholders’ Meeting of HBM Healthcare Investments approved all proposals by the Board of Directors	Jun. 19	EQ
Key Figures 15.06.2023	Jun. 16	EQ

No results for this search